Outcomes in world health organization group II pulmonary hypertension: Mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension

Journal of Cardiac Failure

Volumn 20, Issue 7, 2014, Pages 467-475

  Salamon, Jason N ^a   Kelesidis, Iosif ^b   Msaouel, Pavlos ^a   Mazurek, Jeremy A ^b   Mannem, Santhosh ^a   Adzic, Aleksandar ^a   Zolty, Ronald ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

diastolic dysfunction; Left heart failure; pulmonary hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; ISOSORBIDE DINITRATE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BLACK PERSON; CARDIOVASCULAR MORTALITY; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC HEART FAILURE; UNITED STATES; CLINICAL TRIAL; COHORT ANALYSIS; ECHOGRAPHY; HEART FAILURE; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; SYSTOLE; TREATMENT OUTCOME; TRENDS; VERY ELDERLY; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MORTALITY; PATIENT READMISSION; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84903845303     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.05.003     Document Type: Article

References (51)

1. G. Simonneau Nouvelle classification clinique de l'hypertension pulmonaire [A new clinical classification of pulmonary hypertension] Bull Acad Natl Med 193 2009 1897 1909
2. M.M. Hoeper, J.A. Barbera, R.N. Channick, P.M. Hassoun, I.M. Lang, and A. Manes et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S85 96
3. R.J. Oudiz Pulmonary hypertension associated with left-sided heart disease Clin Chest Med 28 2007 233 241
4. J.C. Fang, T. DeMarco, M.M. Givertz, B.A. Borlaug, G.D. Lewis, and J.E. Rame et al. World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult - a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 31 2012 913 933
5. M. Guazzi, and R. Arena Pulmonary hypertension with left-sided heart disease Nat Rev Cardiol 7 2010 648 659
6. M. Guazzi, M. Vicenzi, R. Arena, and M.D. Guazzi Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study Circulation 124 2011 164 174
7. J.F. Delgado, E. Conde, V. Sanchez, F. Lopez-Rios, M.A. Gomez-Sanchez, and P. Escribano et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure Eur J Heart Fail 7 2005 1011 1016
8. S. Ghio, A. Gavazzi, C. Campana, C. Inserra, C. Klersy, and R. Sebastiani et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
9. F. Grigioni, L. Potena, N. Galie, F. Fallani, M. Bigliardi, and F. Coccolo et al. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure J Heart Lung Transplant 25 2006 1241 1246
10. C.S. Lam, V.L. Roger, R.J. Rodeheffer, B.A. Borlaug, F.T. Enders, and M.M. Redfield Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study J Am Coll Cardiol 53 2009 1119 1126
11. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
12. F. Bursi, S.M. McNallan, M.M. Redfield, V.T. Nkomo, C.S. Lam, and S.A. Weston et al. Pulmonary pressures and death in heart failure: a community study J Am Coll Cardiol 59 2012 222 231
13. C.C. Leung, V. Moondra, E. Catherwood, and B.W. Andrus Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction Am J Cardiol 106 2010 284 286
14. S. Schwartzenberg, M.M. Redfield, A.M. From, P. Sorajja, R.A. Nishimura, and B.A. Borlaug Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy J Am Coll Cardiol 59 2012 442 451
15. J. Butler, D.B. Chomsky, and J.R. Wilson Pulmonary hypertension and exercise intolerance in patients with heart failure J Am Coll Cardiol 34 1999 1802 1806
16. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
17. D. Lloyd-Jones, R. Adams, M. Carnethon, G. de Simone, T.B. Ferguson, and K. Flegal et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 181
18. K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis J Am Coll Cardiol 43 2004 317 327
19. Meta-analysis Global Group in Chronic Heart Failure The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Eur Heart J 33 2012 1750 1757
20. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
21. W.J. Paulus, C. Tschope, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, and F.E. Rademakers et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
22. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, and O.A. Smiseth et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography Eur J Echocardiogr 10 2009 165 193
23. T. Damy, K.M. Goode, A. Kallvikbacka-Bennett, C. Lewinter, J. Hobkirk, and N.P. Nikitin et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure Eur Heart J 31 2010 2280 2290
24. H.J. Willens, and K.M. Kessler Severe pulmonary hypertension associated with diastolic left ventricular dysfunction Chest 103 1993 1877 1883
25. J. Hurdman, R. Condliffe, C.A. Elliot, C. Davies, C. Hill, and J.M. Wild et al. ASPIRE registry: Assessing the Spectrum of Pulmonary Hypertension Identified at a Referral Centre Eur Respir J 39 2012 945 955
26. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, and J.R. Lindner et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association, developed in collaboration with the American College of Chest Physicians; American Thoracic Society; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
27. M. Enriquez-Sarano, A. Rossi, J.B. Seward, K.R. Bailey, and A.J. Tajik Determinants of pulmonary hypertension in left ventricular dysfunction J Am Coll Cardiol 29 1997 153 159
28. Y. Neuman, A. Kotliroff, T. Bental, R.J. Siegel, D. David, and M. Lishner Pulmonary artery pressure and diastolic dysfunction in normal left ventricular systolic function Int J Cardiol 127 2008 174 178
29. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, and A. Haouzi et al. Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
30. United States Census Bureau. Census 2010. Washington, DC; 2010. Available at: http://www.census.gov/easystats/. Accessed October 20, 2013.
31. C.W. Yancy Heart failure in African Americans Am J Cardiol 96 7B 2005 3i 12i
32. L.R. Loehr, W.D. Rosamond, P.P. Chang, A.R. Folsom, and L.E. Chambless Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study) Am J Cardiol 101 2008 1016 1022
33. H. Bahrami, R. Kronmal, D.A. Bluemke, J. Olson, S. Shea, and K. Liu et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis Arch Intern Med 168 2008 2138 2145
34. United States Census Bureau. U.S. census population projections. Washington, DC; 2012. Available at: http://www.census.gov/population/ projections/data/national/2012/summarytables.html. Accessed October 20, 2013.
35. T.E. Owan, and M.M. Redfield Epidemiology of diastolic heart failure Prog Cardiovasc Dis 47 2005 320 332
36. C. Berry, K. Hogg, J. Norrie, K. Stevenson, M. Brett, and J. McMurray Heart failure with preserved left ventricular systolic function: a hospital cohort study Heart 91 2005 907 913
37. P.A. McCullough, A.K. Khandelwal, J.E. McKinnon, H.J. Shenkman, V. Pampati, and D. Nori et al. Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America Congest Heart Fail 11 2005 6 11
38. M.J. Lenzen, W.J. Scholte op Reimer, E. Boersma, P.J. Vantrimpont, F. Follath, and K. Swedberg et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220
39. F. Gustafsson, C. Torp-Pedersen, B. Brendorp, M. Seibaek, H. Burchardt, and L. Kober et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur Heart J 24 2003 863 870
40. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, and G. Lewis et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
41. A.F. Hernandez, B.G. Hammill, C.M. O'Connor, K.A. Schulman, L.H. Curtis, and G.C. Fonarow Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol 53 2009 184 192
42. R.V. Shah, A.S. Desai, and M.M. Givertz The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis J Card Fail 16 2010 260 267
43. F. Edelmann, R. Wachter, A.G. Schmidt, E. Kraigher-Krainer, C. Colantonio, and W. Kamke et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
44. R.M. Califf, K.F. Adams, W.J. McKenna, M. Gheorghiade, B.F. Uretsky, and S.E. McNulty et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54
45. I. Anand, J. McMurray, J.N. Cohn, M.A. Konstam, T. Notter, and K. Quitzau et al. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial Lancet 364 9431 2004 347 354
46. M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M.D. Guazzi Long-term use of sildenafil in the therapeutic management of heart failure J Am Coll Cardiol 50 2007 2136 2144
47. M. Senni, C.M. Tribouilloy, R.J. Rodeheffer, S.J. Jacobsen, J.M. Evans, and K.R. Bailey et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 1998 2282 2289
48. H.M. Krumholz, Z. Lin, P.S. Keenan, J. Chen, J.S. Ross, and E.E. Drye et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia JAMA 309 2013 587 593
49. T. Thenappan, S.J. Shah, M. Gomberg-Maitland, B. Collander, A. Vallakati, and P. Shroff et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction Circ Heart Fail 4 2011 257 265
50. M. McGoon, D. Gutterman, V. Steen, R. Barst, D.C. McCrory, and T.A. Fortin et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 1 Suppl 2004 14S 34S
51. A. Carlos, and J.A. Roldan Evaluation of the patient with heart disease: integrating the physical exam & echocardiography 2002 Lippincott Williams & Wilkins Philadelphia